[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China].
Li L, Zhong W, Liao M, Chen L, Han B, Guan Z, Yu S, Liu X, Wu Y, Jiang G, Xu J, Chen J, Tao M, Luo R, Li W, Xu N, Zhao X, Wang M.
Li L, et al. Among authors: zhong w.
Zhongguo Fei Ai Za Zhi. 2012 Jun;15(6):332-9. doi: 10.3779/j.issn.1009-3419.2012.06.03.
Zhongguo Fei Ai Za Zhi. 2012.
PMID: 22681919
Free PMC article.
Chinese.